Currently, stem cells and transplants are reserved for people whose diabetes cannot be controlled by the standard treatments.

Type 1 diabetes rates are rising, but breakthrough drugs and devices are changing what it means to live with the disease.

Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients with Type ...

Type 1 diabetes is a chronic condition caused by an autoimmune reaction, in which your body attacks the cells in your pancreas that make the hormone insulin. Treatment typically involves daily ...

Type 1 diabetes is a major autoimmune disorder that affects millions of Americans each year. The disease is a result of the body not producing enough insulin, which breaks down glucose for cells to ...

Metformin is the most common medication used to treat type 2 diabetes. It's sometimes used to treat type 1 diabetes in people who still have some insulin production, along with insulin.

Researchers at Karolinska Institutet, KTH Royal Institute of Technology and SciLifeLab have developed a new method for ...

For those with Type 1 diabetes, despite the remarkable new drugs and devices, blood sugar control is seemingly getting worse, on average, not better. As of 2018, fewer than one in five individuals ...

Technology is making rapid advances in treating type 1 diabetes, which occurs when the pancreas stops producing insulin. Continuous glucose monitoring systems allow patients to manage their blood ...

An immunotherapy to treat type 1 diabetes for people with the human leukocyte antigen DR3-DQ2 genotype received its second fast-track designation from the FDA, according to a company press release ...

BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

The benefits of type 1 diabetes screening have long been up for debate, but FDA approval of the first therapy to delay the disease’s onset may be changing the conversation.In November, the FDA ...